Live feed08:30:00·1696dPRReleasevia QuantisnowAzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal InfectionsByQuantisnow·Wall Street's wire, on your screen.AZRX· AzurRx BioPharma, Inc.Health Care
